德国医疗保健质量和效率研究所发布快速报告，指出Optune能为新诊断的胶质母细胞瘤患者带来生存获益 Read more about 德国医疗保健质量和效率研究所发布快速报告，指出Optune能为新诊断的胶质母细胞瘤患者带来生存获益
Entasis Therapeutics于2019年美国微生物学会年会上公布多种病原体靶向抗菌研发项目的积极结果 Read more about Entasis Therapeutics于2019年美国微生物学会年会上公布多种病原体靶向抗菌研发项目的积极结果
再鼎医药及其合作伙伴Entasis Therapeutics宣布已完成ATTACK 3期注册临床研究的患者入组 Read more about 再鼎医药及其合作伙伴Entasis Therapeutics宣布已完成ATTACK 3期注册临床研究的患者入组
FDA Grants Breakthrough Therapy Designation for Cullinan Oncology’s CLN-081 in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer - SC Read more about FDA Grants Breakthrough Therapy Designation for Cullinan Oncology’s CLN-081 in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer - SC
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer - SC Read more about Novocure Announces Last Patient Enrolled in Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-small Cell Lung Cancer - SC
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma - SC Read more about 2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma - SC
Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor Treating Fields in Ovarian Cancer - SC Read more about Novocure Announces Last Patient Enrolled in Phase 3 Pivotal INNOVATE-3 Trial of Tumor Treating Fields in Ovarian Cancer - SC
Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer - SC Read more about Mirati Therapeutics Announces Positive Phase 2 Topline Results for Investigational Adagrasib in Patients with KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer - SC